NCT02978261 Study of a c-Met Inhibitor PLB1001 in Patients With PTPRZ1-MET Fusion Gene Positive Recurrent High-grade Gliomas Status COMPLETED Phase PHASE1
NCT02960230 H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas Status COMPLETED Phase PHASE1/PHASE2
NCT02941302 Multimodality Imaging Combined With Multiple Targets Pathological Examination for Detecting of Biological Borders of Gliomas: a Clinical Application Study Status UNKNOWN Phase NA
NCT02924038 A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) Status TERMINATED Phase PHASE1
NCT02919865 MR Perfusion Methods in Patients With Suspected Recurrent High Grade Gliomas Status COMPLETED Phase NA
NCT02919332 Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma Status WITHDRAWN Phase N/A
NCT02901925 A Microdose Evaluation Study of ABY-029 in Recurrent Glioma Status COMPLETED Phase EARLY_PHASE1
NCT02833701 Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma Status TERMINATED Phase PHASE1
NCT02805179 A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma Status COMPLETED Phase PHASE2
NCT02800486 Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA Status RECRUITING Phase PHASE2
NCT02798406 Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects Status COMPLETED Phase PHASE2
NCT02795364 Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas Status UNKNOWN Phase NA
NCT02783495 Feasibility And Efficacy Of An iPad-Based Cognitive Rehabilitation Program In Brain Tumor Patients Status TERMINATED Phase NA
NCT02754362 A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma Status WITHDRAWN Phase PHASE2